Sanofi India Ltd. - Research Center
500674 SANOFI Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Dec ' 21 | Dec ' 20 | Dec ' 19 | Dec ' 18 | Dec ' 17 | |
|---|---|---|---|---|---|
| Sales | 2,956.60 | 2,901.90 | 3,070.60 | 2,770.80 | 2,491.40 |
| Operating profit | 762.50 | 713.10 | 665.30 | 623.50 | 537.20 |
| Interest | 1.80 | 1.80 | 0.30 | 0.70 | 1.10 |
| Gross profit | 835.10 | 801.10 | 759.10 | 712.50 | 616.80 |
| EPS (Rs) | 410.61 | 207.65 | 180.09 | 165.48 | 141.74 |
Annual
results in details
| Dec ' 21 | Dec ' 20 | Dec ' 19 | Dec ' 18 | Dec ' 17 | |
|---|---|---|---|---|---|
| Other income | 74.40 | 89.80 | 94.10 | 89.70 | 80.70 |
| Stock adjustment | 43.10 | 57.50 | 2.30 | -60.50 | 97.70 |
| Raw material | 555.10 | 591.40 | 863.60 | 801.00 | 615.20 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 433.90 | 460.80 | 449.70 | 406.80 | 368.50 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,162.00 | 1,079.10 | 1,089.70 | 1,000.00 | 872.80 |
| Provisions made | - | - | - | - | - |
| Depreciation | 66.70 | 82.20 | 99.90 | 102.70 | 102.20 |
| Taxation | 313.20 | 199.60 | 185.70 | 229.20 | 188.60 |
| Net profit / loss | 944.40 | 477.60 | 414.20 | 380.60 | 326.00 |
| Extra ordinary item | 489.20 | -41.70 | -59.30 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 25.79 | 24.57 | 21.67 | 22.50 | 21.56 |
| GPM (%) | 27.55 | 26.78 | 23.99 | 24.91 | 23.98 |
| NPM (%) | 31.16 | 15.96 | 13.09 | 13.31 | 12.67 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis